Clinicians’ Assessment of Mobile Diabetes Monitoring: A Comparative Study in Japan and Spain
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
Background: In recent years, the shortage of clinicians has been becoming a serious problem in many developed countries. Increasing medical costs and aging would make this problem even more difficult to be resolved. In this light, mobile-based health monitoring has received increasing attention by hospital administrators and healthcare service professionals, because it enables clinicians to closely monitor and control patients’ health conditions.
Objective: This study compares clinicians’ perceptions on factors determining mobile diabetes monitoring adoption in Japan and Spain. The study proposes a causal model consisting of personal innovativeness, innovation characteristics (perceived value, perceived ubiquity, and self-efficacy), and behavioral intention. In addition, based on the conceptualization of clinician-patient distance in healthcare service and technology readiness scores, moderating effects of country is posited for the constructs relationships.
Methods: The model is tested by empirical surveys in Japan and Spain. In total, 471 and 501 usable responses are obtained from Japanese and Spanish clinicians, respectively. The data are analyzed by structural equation modeling.
Results: Our baseline model fits our data reasonably well in both countries. Our structural equation modeling indicates that all hypothesized paths were supported. A series of fit indexed prove that the model is sufficiently robust across the countries. Japanese clinicians perceived ubiquitous nature of mobile service more strongly, compared with their Spanish counterparts. A multigroup analysis reveals that the country moderates the path from perceived ubiquity to behavioral intention in a way that, in the country with greater clinician-patient distance, the relationship between perceived ubiquity and behavioral intention is strengthened.
Conclusions: Perceived value, perceived ubiquity, and self-efficacy are the primary drivers that enhance the adoption of mobile diabetes monitoring. Results from this survey demonstrate that countries with greater clinician-patient distance may exhibit stronger intention to adopt mobile-based diabetes monitoring.
Objective: This study compares clinicians’ perceptions on factors determining mobile diabetes monitoring adoption in Japan and Spain. The study proposes a causal model consisting of personal innovativeness, innovation characteristics (perceived value, perceived ubiquity, and self-efficacy), and behavioral intention. In addition, based on the conceptualization of clinician-patient distance in healthcare service and technology readiness scores, moderating effects of country is posited for the constructs relationships.
Methods: The model is tested by empirical surveys in Japan and Spain. In total, 471 and 501 usable responses are obtained from Japanese and Spanish clinicians, respectively. The data are analyzed by structural equation modeling.
Results: Our baseline model fits our data reasonably well in both countries. Our structural equation modeling indicates that all hypothesized paths were supported. A series of fit indexed prove that the model is sufficiently robust across the countries. Japanese clinicians perceived ubiquitous nature of mobile service more strongly, compared with their Spanish counterparts. A multigroup analysis reveals that the country moderates the path from perceived ubiquity to behavioral intention in a way that, in the country with greater clinician-patient distance, the relationship between perceived ubiquity and behavioral intention is strengthened.
Conclusions: Perceived value, perceived ubiquity, and self-efficacy are the primary drivers that enhance the adoption of mobile diabetes monitoring. Results from this survey demonstrate that countries with greater clinician-patient distance may exhibit stronger intention to adopt mobile-based diabetes monitoring.
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.